글로벌 중재적 종양학 장비 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 중재적 종양학 장비에 대한 통찰력

중재적 종양학 장비 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 2028년까지 시장이 37억 5천만 달러에 이를 것으로 분석하고, 위에 언급된 예측 기간 동안 6.95%의 CAGR로 성장할 것입니다.

중재적 종양학은 영상 가이드 하에 수행되는 표적 최소 침습적 시술의 도움으로 다양한 암을 치료하는 것을 주로 다룹니다. 또한 기존의 개방 수술에 비해 회복 시간이 빠릅니다.

증가하는 공공-민간 자금 지원과 개입 종양학 에 대한 정부 지원 은 개입 종양학 장비 시장의 성장과 수요를 강화하는 중요한 요인 중 하나입니다. 또한, 개입 종양학의 빠른 기술 발전과 대상 환자 인구의 증가도 2021년에서 2028년까지의 예측 기간 동안 글로벌 시장 성장에 기여하고 있습니다. 또한 최소 침습적 시술 에 대한 환자 선호도가 증가함에 따라 시장 성장이 촉진되고 있습니다. 나아가 전 세계적으로 암 발병률이 빠르게 증가하고 선진국에서 정부의 자금 지원이 개선된 것도 개입 종양학 장비 시장 성장을 촉진하는 중요한 요인 중 하나입니다. 개입 종양학 치료에 대한 유리한 상환 시나리오는 예측 기간 동안 높은 산업 성장을 보장할 것입니다.

개입적 종양학의 이점에 대한 인식이 높아지고 업계 참여자 사이에서 제품 출시가 늘어나고 합병 ​​및 인수가 확대됨에 따라 2021년에서 2028년까지의 예측 기간 동안 시장에 상당한 성장 기회가 제공되고 있습니다.

However, the product recalls and lack of clinical evidence for localized region treatment as well as unfavorable regulations will curb the growth of the interventional oncology devices market, whereas the inadequate clinical data to support therapeutic efficiency and  dearth of well-trained and skilled oncologists have the potential to challenge the growth of the interventional oncology devices market.

This interventional oncology devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on interventional oncology devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Interventional Oncology Devices Market Scope and Market Size

Interventional oncology devices market is segmented on the basis of product type, cancer type and procedure. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on product type, the interventional oncology devices market is segmented into embolization devices, ablation devices, support devices and next-gen devices. Embolization devices have further been segmented into transcatheter arterial radioembolization, transcatheter arterial chemoembolization and transcatheter arterial embolization. Ablation devices have further been segmented into radiofrequency ablation, microwave ablation and cryoablation. Support devices have further been segmented into catheters and guidewires. Next-gen devices have further been segmented into irreversible electroporation ablation, percutaneous ethanol ablation, high-intensity focused ultrasound, laser ablation, photothermal ablation and theranostics.
• On the basis of cancer type, the interventional oncology devices market is segmented into liver cancer, prostate cancer, breast cancer, lung cancer, bone cancer, kidney cancer and others.
• The procedure segment of interventional oncology devices market is segmented into thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization, transcatheter arterial radioembolization/selective internal radiation therapy and transcatheter arterial embolization/bland embolization.

 Interventional Oncology Devices Market Country Level Analysis

Interventional oncology devices market is analyzed and market size insights and trends are provided by country, product type, cancer type and procedure as referenced above.

The countries covered in the interventional oncology devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the interventional oncology devices market owing to the rapid advancements in technology and easy affordability to minimally invasive procedures for the efficient management of cancer in the developed countries within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rising adoption of interventional oncology procedures along with rising incidence of cancer and the increasing geriatric population within this particular region.

The country section of the interventional oncology devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Interventional oncology devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for interventional oncology devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the interventional oncology devices market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Interventional Oncology Devices Market Share Analysis

중재적 종양학 장치 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 중재적 종양학 장치 시장과 관련된 회사의 초점에만 관련이 있습니다.

중재적 종양학 장치 시장 보고서에서 다루는 주요 기업으로는 Medtronic, Boston Scientific Corporation, Terumo Europe NV, Merit Medical Systems, Sirtex Medical Limited, AngioDynamics, Johnson & Johnson Services, Inc., Teleflex Incorporated, Cook, Varian Medical Systems, Inc., Eckert & Ziegler BEBIG, 3M, MedWaves, Inc., IMBIOTECHNOLOGIES LTD., Trod Medical, Smiths Medical, NEWTECH MEDICAL DEVICES, IceCure Medical Ltd, Accuray Incorporated, Sanarus 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-33976